Gentile, Francesco http://orcid.org/0000-0002-1847-5608
Terenghi, Fabrizia http://orcid.org/0000-0002-4708-7380
Doneddu, Pietro Emiliano http://orcid.org/0000-0003-4203-6792
De Lorenzo, Alberto http://orcid.org/0000-0002-9479-9444
Giannotta, Claudia http://orcid.org/0000-0002-8175-3842
Giordano, Andrea
Mazza, Rita http://orcid.org/0000-0003-2999-3678
Nozza, Andrea
Nobile-Orazio, Eduardo http://orcid.org/0000-0003-2624-8138
Funding for this research was provided by:
Università degli Studi di Milano
Article History
Received: 29 June 2023
Accepted: 4 September 2023
First Online: 13 September 2023
Declarations
:
: Approval by Ethic Committee was not required as this is a retrospective study on data and test routinely collected during regular clinical activity. All the patients admitted to the Hospital had signed a consensus for the use of their clinical and laboratory results for research purpose.
: Pietro Emiliano Doneddu has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Eduardo Nobile-Orazio reports personal fees for Advisory or Scientific Board from ArgenX, Belgium, Takeda, Italy and USA, CSL-Behring, Italy and USA, Janssen, USA, Kedrion, Italy, LFB, France, Roche, Switzerland, Sanofi, USA. The other authors declare no conflict of interest.